MITCHELL SHUSTER STEINER
CIK 1276244 · President and CEO · last filed 2026-05-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$21.45M
Companies
3
Total Filings
69
Lifetime Open-Market Net
-$8.59M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VERU | President and CEO | 7,150,388 | $3.00 | $21.45M | -$3.58M | 44 | 2026-05-06 |
| VERU INC. (FHCO) Delisted | President and CEO | 7,759,142 | — | — | $70.1K | 3 | 2017-08-04 |
| Oncternal Therapeutics, Inc. (GTXI) Delisted | Chief Executive Officer | 2,398,853 | — | — | -$5.08M | 22 | 2014-01-31 |
Recent Filings · Page 7 of 7
69 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-01-05 | Oncternal Therapeutics, Inc. (GTXI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-11-12 | Oncternal Therapeutics, Inc. (GTXI) Delisted | Buy (P) | +2,030 | $7.6K | EDGAR |
| 2009-02-02 | Oncternal Therapeutics, Inc. (GTXI) Delisted | Buy (P) | +1,700 | $18.1K | EDGAR |
| 2009-01-28 | Oncternal Therapeutics, Inc. (GTXI) Delisted | Buy (P) | +1,700 | $17.9K | EDGAR |
| 2009-01-27 | Oncternal Therapeutics, Inc. (GTXI) Delisted | Buy (P) | +1,700 | $17.9K | EDGAR |
| 2009-01-05 | Oncternal Therapeutics, Inc. (GTXI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-09-16 | Oncternal Therapeutics, Inc. (GTXI) Delisted | Other (J) | — | $0 | EDGAR |
| 2007-07-02 | Oncternal Therapeutics, Inc. (GTXI) Delisted | Gift (G) | — | $0 | EDGAR |
| 2007-03-14 | Oncternal Therapeutics, Inc. (GTXI) Delisted | Mixed | −200,000 | -$4.42M | EDGAR |
Showing 61–69 of 69
Prev
Page 7 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.